Calculate how many units to draw for your BPC-157 dose. Pre-filled with common protocol presets from 100mcg through 750mcg.
BPC-157 protocols vary based on goals and duration. These are widely referenced dosing approaches in the research and user community.
The most commonly referenced BPC-157 protocol. Once-daily subcutaneous injection, typically administered in the morning. Often run for 4-8 weeks.
Split across AM and PM administrations. With BPC-157's approximately 4-hour half-life, twice-daily dosing maintains more consistent blood concentration levels throughout the day.
A higher single dose approach. Some users reference this for the first 1-2 weeks before transitioning to the standard 250mcg dose for the remainder of the cycle.
BPC-157 has a half-life of approximately 4 hours. Unlike weekly GLP-1 peptides, it is typically administered once or twice daily via subcutaneous injection.
Common protocol durations range from 4 to 12 weeks. Many users run 4-8 week cycles. Protocol length is a frequently discussed variable in the research community.
BPC-157 (Body Protection Compound-157) is a 15-amino-acid peptide originally isolated from gastric juice. This origin is why oral administration is discussed as a potential route alongside subcutaneous injection.
Reconstituted BPC-157 is typically stored refrigerated at 2-8 degrees Celsius. Using bacteriostatic water supports multi-use stability for approximately 4-6 weeks.
1 mL = 100 units (IU) on a standard U-100 insulin syringe
Short half-life means twice-daily dosing provides more consistent levels
Often stacked with TB-500 in recovery-focused protocols
Store reconstituted vials refrigerated (2-8°C) and use within 4-6 weeks